INCOME/LOSS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table presents the calculation of basic and diluted income/loss per share of common stock:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
	(In thousands, except share and per share data)
Numerator:
Net income (loss) attributable to Acacia Research Corporation	$	28,090	$	89,757	$	(106,679)	$	(55,048)
Dividend on Series A redeemable convertible preferred stock	(700)		(262)		(2,099)		(785)
Accretion of Series A redeemable convertible preferred stock	(1,337)		(991)		(3,729)		(2,762)
Undistributed earnings allocated to participating securities	(5,466)		(15,394)		—		—
Net income (loss) attributable to common stockholders - Basic	20,587		73,110		(112,507)		(58,595)
Less: Change in fair value of Series A warrants	(3,389)		63		—		—
Less: Change in fair value of dilutive Series B warrants	(21,766)		(902)		—		—
Add: Interest expense associated with Starboard Notes,    net of tax	850		1,536		—		—
Add: Undistributed earnings allocated to participating    securities	5,466		15,394		—		—
Reallocation of undistributed earnings to participating    securities	(217)		(8,893)		—		—
Net income (loss) attributable to common stockholders - Diluted	$	1,531	$	80,308	$	(112,507)	$	(58,595)
Denominator:
Weighted average shares used in computing net income (loss)    per share attributable to common stockholders - Basic	38,052,426		48,949,504		42,830,700		48,759,873
Potentially dilutive common shares:
Restricted stock units	539,989		798,356		—		—
Stock options	18,397		35,815		—		—
Series A Warrants	1,046,575		2,019,724		—		—
Series B Warrants	31,506,849		41,278,103		—		—
Weighted average shares used in computing net income (loss)    per share attributable to common stockholders - Diluted	71,164,236		93,081,502		42,830,700		48,759,873
Basic net income (loss) per common share	$	0.54	$	1.49	$	(2.63)	$	(1.20)
Diluted net income (loss) per common share	$	0.02	$	0.86	$	(2.63)	$	(1.20)
Anti-dilutive potential common shares excluded from the    computation of diluted net income/loss per share:
Equity-based incentive awards	1,027,082		398,168		3,217,890		2,230,624
Series A warrants	—		—		5,000,000		5,000,000
Series B warrants	68,493,151		—		100,000,000		100,000,000
Total	69,520,233		398,168		108,217,890		107,230,624